Welcome to the Trial Talks podcast, a thought-provoking show about clinical research. On this podcast, we will be exploring trends in the industry as well as the changing landscape, pandemic impact, various types of research, and more.
Today, I’ll be talking with Donna Chang, the CEO and founder of Hope Biosciences. Hope Biosciences focuses on stem cell research to prevent disease and degeneration. In this episode we will be talking about the progress that has been made in the last decade, with regards to stem cell research. We’ll also be talking about stem cell research and COVID-19.
Talking Points:
Resources/Links:
Official website: Hope Biosciences
Approximately 39.5% of all men and women will be diagnosed with cancer at some point during their lifetimes, and yet only 8% of oncology...
Australia and New Zealand have not been impacted as much as North America and the EU with regards to COVID-19. For this reason, and...
Constantly changing regulations and a multitude of new endpoints continue to keep clinical researchers on their toes. While these regulations and endpoints are designed...